Total Payments
$2,799
2024 Payments
$1,019
Companies
41
Transactions
118
Medicare Patients
2,597
Medicare Billing
$220,137
Payment Breakdown by Category
Food & Beverage$2,799 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,799 | 118 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $747.99 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $387.76 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $190.45 | 12 | $0 (2024) |
| Novo Nordisk Inc | $145.00 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $135.29 | 8 | $0 (2024) |
| PFIZER INC. | $108.27 | 6 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $102.60 | 1 | $0 (2018) |
| Genentech USA, Inc. | $86.23 | 4 | $0 (2022) |
| Astellas Pharma US Inc | $58.90 | 3 | $0 (2023) |
| Lilly USA, LLC | $55.58 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,019 | 21 | Supernus Pharmaceuticals, Inc. ($689.36) |
| 2023 | $592.25 | 28 | GlaxoSmithKline, LLC. ($228.04) |
| 2022 | $289.79 | 19 | Merck Sharp & Dohme LLC ($66.15) |
| 2021 | $311.01 | 20 | GlaxoSmithKline, LLC. ($57.98) |
| 2020 | $136.61 | 8 | Genentech USA, Inc. ($47.51) |
| 2019 | $290.13 | 17 | Amarin Pharma Inc. ($47.35) |
| 2018 | $132.87 | 3 | AMAG Pharmaceuticals, Inc. ($102.60) |
| 2017 | $26.81 | 2 | Lilly USA, LLC ($15.19) |
All Payment Transactions
118 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: VACCINES | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: VACCINE | ||||||
| 11/08/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: PAIN | ||||||
| 10/30/2024 | Exact Sciences Corporation | — | Food and Beverage | In-kind items and services | $14.94 | General |
| 10/24/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Respiratory | ||||||
| 08/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: DIABETES | ||||||
| 08/16/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: PAIN | ||||||
| 08/15/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: VACCINE | ||||||
| 06/18/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, AREXVY | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: VACCINES | ||||||
| 06/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 05/31/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: PAIN | ||||||
| 03/22/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: PAIN | ||||||
| 03/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: VACCINE | ||||||
| 01/31/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $674.40 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Diabetes | ||||||
| 12/04/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, AREXVY | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: VACCINES | ||||||
| 11/07/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Biological | ||||||
| 11/01/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Diabetes | ||||||
| 10/26/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 534 | 783 | $125,967 | $52,850 |
| 2022 | 9 | 589 | 871 | $108,932 | $53,372 |
| 2021 | 10 | 684 | 950 | $97,174 | $57,390 |
| 2020 | 12 | 790 | 1,092 | $112,974 | $56,524 |
Total Patients
2,597
Total Services
3,696
Medicare Billing
$220,137
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 294 | $70,037 | $25,021 | 35.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 97 | 97 | $15,520 | $12,319 | 79.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $15,789 | $4,785 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 71 | $11,959 | $4,104 | 34.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 28 | 28 | $3,360 | $2,014 | 59.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 123 | 200 | $3,400 | $1,680 | 49.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $4,024 | $1,607 | 39.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $728.00 | $713.44 | 98.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $774.00 | $545.40 | 70.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 18 | $375.84 | $61.38 | 16.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 142 | 316 | $59,792 | $25,895 | 43.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 90 | 90 | $14,400 | $11,673 | 81.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 92 | $11,246 | $5,566 | 49.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 15 | 15 | $11,522 | $4,171 | 36.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 48 | 48 | $5,498 | $3,277 | 59.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 49 | 49 | $1,545 | $1,374 | 88.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 24 | 24 | $937.95 | $705.60 | 75.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 127 | 219 | $3,723 | $648.54 | 17.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 17 | 18 | $268.92 | $61.92 | 23.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 159 | 306 | $52,020 | $27,824 | 53.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 99 | 99 | $15,840 | $13,099 | 82.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 89 | $9,345 | $5,367 | 57.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 62 | 63 | $4,247 | $4,107 | 96.7% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 19 | 19 | $2,929 | $2,380 | 81.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $5,600 | $2,347 | 41.9% |
About Dr. Amber Robinson, D.O
Dr. Amber Robinson, D.O is a General Practice healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2009. The National Provider Identifier (NPI) number assigned to this provider is 1275761082.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amber Robinson, D.O has received a total of $2,799 in payments from pharmaceutical and medical device companies, with $1,019 received in 2024. These payments were reported across 118 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($2,799).
As a Medicare-enrolled provider, Robinson has provided services to 2,597 Medicare beneficiaries, totaling 3,696 services with total Medicare billing of $220,137. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Other Specialties Family Medicine
- Location Fort Worth, TX
- Active Since 06/30/2009
- Last Updated 04/11/2022
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1275761082
Products in Payments
- Qelbree (Drug) $689.36
- JARDIANCE (Drug) $164.57
- NURTEC ODT (Drug) $156.88
- AREXVY (Drug) $138.62
- SHINGRIX (Biological) $133.11
- INTRAROSA (Drug) $102.60
- Xofluza (Drug) $86.23
- GARDASIL 9 (Biological) $80.26
- TRELEGY ELLIPTA (Drug) $76.68
- QELBREE (Drug) $58.63
- GARDASIL (Biological) $49.84
- Vascepa (Drug) $47.35
- Rybelsus (Drug) $45.95
- Veozah (Drug) $44.03
- JANUVIA (Drug) $39.81
- UBRELVY (Drug) $39.59
- BEXSERO (Biological) $39.35
- INJECTAFER (Drug) $37.64
- QULIPTA (Drug) $37.52
- Kyleena (Drug) $36.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Fort Worth
Dr. Gordon Damon, Dds, DDS
General Practice — Payments: $32,616
General Practice $32,616
Edward Reiter, D.d.s, D.D.S
General Practice — Payments: $24,391
General Practice $24,391
William Roddy, D.d.s, D.D.S
General Practice — Payments: $18,202
General Practice $18,202
Jessica Brigati, D.d.s, D.D.S
General Practice — Payments: $11,373
General Practice $11,373
Dr. Chirag Patel, D.d.s, D.D.S
General Practice — Payments: $8,220
General Practice $8,220
Dr. Saam Zarrabi, Dds, DDS
General Practice — Payments: $8,135
General Practice $8,135